183 related articles for article (PubMed ID: 17119285)
1. The role of aluminum and copper on neuroinflammation and Alzheimer's disease.
Campbell A
J Alzheimers Dis; 2006 Nov; 10(2-3):165-72. PubMed ID: 17119285
[TBL] [Abstract][Full Text] [Related]
2. Aluminum and copper interact in the promotion of oxidative but not inflammatory events: implications for Alzheimer's disease.
Becaria A; Bondy SC; Campbell A
J Alzheimers Dis; 2003 Feb; 5(1):31-8. PubMed ID: 12590164
[TBL] [Abstract][Full Text] [Related]
3. Aluminum and other metals in Alzheimer's disease: a review of potential therapy with chelating agents.
Domingo JL
J Alzheimers Dis; 2006 Nov; 10(2-3):331-41. PubMed ID: 17119296
[TBL] [Abstract][Full Text] [Related]
4. Aluminum induced oxidative events and its relation to inflammation: a role for the metal in Alzheimer's disease.
Campbell A; Bondy SC
Cell Mol Biol (Noisy-le-grand); 2000 Jun; 46(4):721-30. PubMed ID: 10875435
[TBL] [Abstract][Full Text] [Related]
5. Blood-brain barrier flux of aluminum, manganese, iron and other metals suspected to contribute to metal-induced neurodegeneration.
Yokel RA
J Alzheimers Dis; 2006 Nov; 10(2-3):223-53. PubMed ID: 17119290
[TBL] [Abstract][Full Text] [Related]
6. Type-I interferon pathway in neuroinflammation and neurodegeneration: focus on Alzheimer's disease.
Taylor JM; Moore Z; Minter MR; Crack PJ
J Neural Transm (Vienna); 2018 May; 125(5):797-807. PubMed ID: 28676934
[TBL] [Abstract][Full Text] [Related]
7. Metallostasis in Alzheimer's disease.
Ayton S; Lei P; Bush AI
Free Radic Biol Med; 2013 Sep; 62():76-89. PubMed ID: 23142767
[TBL] [Abstract][Full Text] [Related]
8. Aluminum and copper in drinking water enhance inflammatory or oxidative events specifically in the brain.
Becaria A; Lahiri DK; Bondy SC; Chen D; Hamadeh A; Li H; Taylor R; Campbell A
J Neuroimmunol; 2006 Jul; 176(1-2):16-23. PubMed ID: 16697052
[TBL] [Abstract][Full Text] [Related]
9. Brain biometals and Alzheimer's disease - boon or bane?
Prakash A; Dhaliwal GK; Kumar P; Majeed AB
Int J Neurosci; 2017 Feb; 127(2):99-108. PubMed ID: 27044501
[TBL] [Abstract][Full Text] [Related]
10. Aluminium and iron, but neither copper nor zinc, are key to the precipitation of beta-sheets of Abeta_{42} in senile plaque cores in Alzheimer's disease.
Exley C
J Alzheimers Dis; 2006 Nov; 10(2-3):173-7. PubMed ID: 17119286
[TBL] [Abstract][Full Text] [Related]
11. Aluminum and Alzheimer's disease: a new look.
Miu AC; Benga O
J Alzheimers Dis; 2006 Nov; 10(2-3):179-201. PubMed ID: 17119287
[TBL] [Abstract][Full Text] [Related]
12. Neuroinflammation, oxidative stress and the pathogenesis of Alzheimer's disease.
Agostinho P; Cunha RA; Oliveira C
Curr Pharm Des; 2010; 16(25):2766-78. PubMed ID: 20698820
[TBL] [Abstract][Full Text] [Related]
13. The role of metals in the etiology of Alzheimer's disease.
Shcherbatykh I; Carpenter DO
J Alzheimers Dis; 2007 May; 11(2):191-205. PubMed ID: 17522444
[TBL] [Abstract][Full Text] [Related]
14. Copper and Alzheimer's Disease.
Mathys ZK; White AR
Adv Neurobiol; 2017; 18():199-216. PubMed ID: 28889269
[TBL] [Abstract][Full Text] [Related]
15. Aluminum exposure through the diet: metal levels in AbetaPP transgenic mice, a model for Alzheimer's disease.
Gómez M; Esparza JL; Cabré M; García T; Domingo JL
Toxicology; 2008 Jul; 249(2-3):214-9. PubMed ID: 18571827
[TBL] [Abstract][Full Text] [Related]
16. Silicic Acid and Beer Consumption Reverses the Metal Imbalance and the Prooxidant Status Induced by Aluminum Nitrate in Mouse Brain.
González-Muñoz MJ; Garcimartán A; Meseguer I; Mateos-Vega CJ; Orellana JM; Peña-Fernández A; Benedí J; Sánchez-Muniz FJ
J Alzheimers Dis; 2017; 56(3):917-927. PubMed ID: 28059788
[TBL] [Abstract][Full Text] [Related]
17. Copper, iron, and zinc imbalances in severely degenerated brain regions in Alzheimer's disease: possible relation to oxidative stress.
Deibel MA; Ehmann WD; Markesbery WR
J Neurol Sci; 1996 Nov; 143(1-2):137-42. PubMed ID: 8981312
[TBL] [Abstract][Full Text] [Related]
18. Aluminium, iron, zinc and copper influence the in vitro formation of amyloid fibrils of Abeta42 in a manner which may have consequences for metal chelation therapy in Alzheimer's disease.
House E; Collingwood J; Khan A; Korchazkina O; Berthon G; Exley C
J Alzheimers Dis; 2004 Jun; 6(3):291-301. PubMed ID: 15201484
[TBL] [Abstract][Full Text] [Related]
19. Longitudinal study of inflammatory factors in serum, cerebrospinal fluid, and brain tissue in Alzheimer disease: interleukin-1beta, interleukin-6, interleukin-1 receptor antagonist, tumor necrosis factor-alpha, the soluble tumor necrosis factor receptors I and II, and alpha1-antichymotrypsin.
Lanzrein AS; Johnston CM; Perry VH; Jobst KA; King EM; Smith AD
Alzheimer Dis Assoc Disord; 1998 Sep; 12(3):215-27. PubMed ID: 9772027
[TBL] [Abstract][Full Text] [Related]
20. Copper(I) and copper(II) inhibit Aβ peptides proteolysis by insulin-degrading enzyme differently: implications for metallostasis alteration in Alzheimer's disease.
Grasso G; Pietropaolo A; Spoto G; Pappalardo G; Tundo GR; Ciaccio C; Coletta M; Rizzarelli E
Chemistry; 2011 Feb; 17(9):2752-62. PubMed ID: 21274957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
